L. Lagneaux et al., TGF-BETA ACTIVITY AND EXPRESSION OF ITS RECEPTORS IN B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA, Leukemia & lymphoma, 31(1-2), 1998, pp. 99
B-cell chronic lymphocytic leukemia (B-CLL) is the most common leukemi
a in Western countries and results from the accumulation of B-lymphocy
tes which are functionally abnormal and predominantly non-cycling in v
ivo. Consequently, it is important to understand why B-CLL cells accum
ulate in G0 phase. Since TGF-beta is an important negative regulator o
f the immune system, a loss of responsiveness to this factor might pro
vide a selective advantage to B-CLL cells. Here we review data on the
role of TGF-beta in B-CLL. We show that the B-CLL cell response to TGF
-beta signals is abnormal in vitro (inhibition of proliferation and in
duction of apoptosis). This lack of response of B-CLL cells to TGF-bet
a inhibition appears to be accompanied by a decrease or a loss of TGF-
beta receptor expression.